Jennifer Landsberg

2.9k total citations
58 papers, 1.4k citations indexed

About

Jennifer Landsberg is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jennifer Landsberg has authored 58 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Oncology, 24 papers in Immunology and 17 papers in Molecular Biology. Recurrent topics in Jennifer Landsberg's work include Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (16 papers) and Epigenetics and DNA Methylation (11 papers). Jennifer Landsberg is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Immunotherapy and Immune Responses (16 papers) and Epigenetics and DNA Methylation (11 papers). Jennifer Landsberg collaborates with scholars based in Germany, United States and Australia. Jennifer Landsberg's co-authors include Dimo Dietrich, Glen Kristiansen, Friedrich Bootz, Jörn Dietrich, Heidrun Gevensleben, Diane Goltz, Timo Vogt, Thomas Tüting, Judith Kohlmeyer and Luka de Vos and has published in prestigious journals such as Nature Communications, Blood and Cancer Research.

In The Last Decade

Jennifer Landsberg

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Landsberg Germany 23 676 595 454 264 231 58 1.4k
Amandine Alard United States 10 851 1.3× 576 1.0× 724 1.6× 315 1.2× 169 0.7× 13 1.6k
Falguni Parikh India 13 747 1.1× 474 0.8× 425 0.9× 155 0.6× 327 1.4× 50 1.3k
Bernhard Reis Switzerland 13 511 0.8× 512 0.9× 507 1.1× 296 1.1× 284 1.2× 25 1.2k
Xuhui Bao United States 14 357 0.5× 475 0.8× 396 0.9× 134 0.5× 240 1.0× 32 1.1k
Kathleen Lambein Belgium 18 743 1.1× 578 1.0× 363 0.8× 133 0.5× 427 1.8× 41 1.5k
Anna Wilkins United Kingdom 16 640 0.9× 340 0.6× 430 0.9× 400 1.5× 140 0.6× 39 1.3k
Toby Mellows United Kingdom 12 885 1.3× 357 0.6× 643 1.4× 244 0.9× 222 1.0× 17 1.5k
Dan S. Gombos United States 22 624 0.9× 457 0.8× 334 0.7× 414 1.6× 210 0.9× 87 1.9k
Ana Carneiro Sweden 16 650 1.0× 467 0.8× 272 0.6× 203 0.8× 145 0.6× 46 1.1k
Philipp Lohneis Germany 19 643 1.0× 265 0.4× 300 0.7× 169 0.6× 206 0.9× 57 1.1k

Countries citing papers authored by Jennifer Landsberg

Since Specialization
Citations

This map shows the geographic impact of Jennifer Landsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Landsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Landsberg more than expected).

Fields of papers citing papers by Jennifer Landsberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Landsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Landsberg. The network helps show where Jennifer Landsberg may publish in the future.

Co-authorship network of co-authors of Jennifer Landsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Landsberg. A scholar is included among the top collaborators of Jennifer Landsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Landsberg. Jennifer Landsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vos, Luka de, Romina Zarbl, Judith Sirokay, et al.. (2024). Circulating Cell-Free SHOX2 DNA Methylation Is a Predictive, Prognostic, and Monitoring Biomarker in Adjuvant and Palliative Anti-PD-1-Treated Melanoma. Clinical Chemistry. 70(3). 516–527. 3 indexed citations
2.
Martins, Christina, Erik Rasbach, Praveen Kumar Singh, et al.. (2024). Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade. Nature Communications. 15(1). 7165–7165. 17 indexed citations
3.
Jansen, Philipp, Maximilian Schmidt, Jennifer Landsberg, et al.. (2023). Deep learning based histological classification of adnex tumors. European Journal of Cancer. 196. 113431–113431. 3 indexed citations
4.
Hillebrand, Philip, et al.. (2023). CD52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma. Pigment Cell & Melanoma Research. 37(2). 309–315. 3 indexed citations
5.
Faron, Anton, Alexander Isaak, Narine Mesropyan, et al.. (2021). Cardiac MRI Depicts Immune Checkpoint Inhibitor–induced Myocarditis: A Prospective Study. Radiology. 301(3). 602–609. 39 indexed citations
6.
Faron, Anton, Muriel Heimann, Anna‐Laura Potthoff, et al.. (2021). Combined Assessment of Preoperative Frailty and Sarcopenia Allows the Prediction of Overall Survival in Patients with Lung Cancer (NSCLC) and Surgically Treated Brain Metastasis. Cancers. 13(13). 3353–3353. 24 indexed citations
7.
Schneider, Matthias, Niklas Schäfer, Christian Bode, et al.. (2021). Prognostic Value of Preoperative Inflammatory Markers in Melanoma Patients with Brain Metastases. Journal of Clinical Medicine. 10(4). 634–634. 12 indexed citations
8.
Schneider, Matthias, Niklas Schäfer, Christian Bode, et al.. (2021). The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival. Journal of Clinical Medicine. 10(17). 4013–4013. 1 indexed citations
9.
Hassel, Jessica C., Elisabeth Livingstone, Jean‐Pierre Allam, et al.. (2021). Fertility preservation and management of pregnancy in melanoma patients requiring systemic therapy. ESMO Open. 6(5). 100248–100248. 18 indexed citations
10.
Fröhlich, Anne, et al.. (2020). Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB–IV M1c melanoma patients. Cancer Immunology Immunotherapy. 69(5). 759–769. 22 indexed citations
11.
Schneider, Matthias, Muriel Heimann, Christina Schaub, et al.. (2020). Comorbidity Burden and Presence of Multiple Intracranial Lesions Are Associated with Adverse Events after Surgical Treatment of Patients with Brain Metastases. Cancers. 12(11). 3209–3209. 20 indexed citations
12.
13.
Hoffmann, Friederike, et al.. (2020). H3K27me3 and EZH2 expression in melanoma: relevance for melanoma progression and response to immune checkpoint blockade. Clinical Epigenetics. 12(1). 24–24. 28 indexed citations
14.
Zarbl, Romina, Dennis Niebel, Christian Posch, et al.. (2020). CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab). Cancer Immunology Immunotherapy. 70(6). 1781–1788. 22 indexed citations
15.
Herrlinger, Ulrich, Stefan Hauser, Franz Bauernfeind, et al.. (2020). Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome. BMC Cancer. 20(1). 355–355. 32 indexed citations
16.
Hoffmann, Friederike, Romina Zarbl, Dennis Niebel, et al.. (2020). Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma. Clinical Epigenetics. 12(1). 94–94. 28 indexed citations
17.
Goltz, Diane, Heidrun Gevensleben, Timo Vogt, et al.. (2018). CTLA4 methylation predicts response to anti–PD-1 and anti–CTLA-4 immunotherapy in melanoma patients. JCI Insight. 3(13). 74 indexed citations
18.
Gevensleben, Heidrun, Jörn Dietrich, Friedrich Bootz, et al.. (2018). PD-1 (PDCD1) Promoter Methylation Is a Prognostic Factor in Patients With Diffuse Lower-Grade Gliomas Harboring Isocitrate Dehydrogenase (IDH) Mutations. EBioMedicine. 28. 97–104. 57 indexed citations
19.
Riesenberg, Stefanie, Robert Siddaway, Tobias Bald, et al.. (2015). MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment. Nature Communications. 6(1). 8755–8755. 153 indexed citations
20.
Landsberg, Jennifer, Evelyn Gaffal, Mira Cron, et al.. (2010). Autochthonous primary and metastatic melanomas in Hgf‐Cdk4R24C mice evade T‐cell‐mediated immune surveillance. Pigment Cell & Melanoma Research. 23(5). 649–660. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amandine Alard Breakdown of academic impact, for papers by Falguni Parikh Breakdown of academic impact, for papers by Bernhard Reis Breakdown of academic impact, for papers by Xuhui Bao Breakdown of academic impact, for papers by Kathleen Lambein Breakdown of academic impact, for papers by Anna Wilkins Breakdown of academic impact, for papers by Toby Mellows Breakdown of academic impact, for papers by Dan S. Gombos Breakdown of academic impact, for papers by Ana Carneiro Breakdown of academic impact, for papers by Philipp Lohneis
Rankless by CCL
2026